20:13 IST
BSE
Annual General Meeting
Aptus Pharma Annual General Meeting
Aptus Pharma Ltd issued a corrigendum to its 16th AGM notice regarding inadvertent errors in the explanatory statement for item no. 3.
Aptus Pharma Ltd
- Share price
- ₹347.00
- Market cap
- ₹595.1 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 128.8×Sector 50.4×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements
16:47 IST
BSE
Earnings Call
Aptus Pharma Earnings Call: Key Takeaways
Aptus Pharma (BSE SME) reports strong growth in FY26 following its 2025 listing. The company operates an asset-light, marketing-focused model with 250+ formulations across diverse therapeutic segments.
19:42 IST
BSE
Financial Results
Aptus Pharma H2 FY26 Results: Net Profit ₹2.9 Cr, Up 61.1% YoY
Aptus Pharma Ltd reported revenue from operations of ₹32.2 Cr (+117.6% YoY) and net profit of ₹2.9 Cr (+61.1% YoY) for H2 FY26.
- Key figure
- Net profit ₹2.9 Cr · +61.1% YoY